Bridging the Gap Between Big Pharma and Startups: Lessons Learned and Opportunities for Collaboration

Synopsis

While big pharma and startups often face different challenges, they both contend with shared issues such as resource constraints, managing space
efficiently, and adapting to regulatory demands. This panel will explore how these two types of organizations can learn from each other to optimize
lab operations, streamline processes, and foster innovation. Panelists will discuss how smaller organizations can leverage the experience of larger
companies, while big pharma can gain insights from the agility and creative problem-solving often seen in startups.
-Key differences in lab management, scalability, and operational strategies between big pharma and scale-ups
-Collaborative opportunities: What startups and big pharma can learn from one another
-Practical tools for startups to implement resource-efficient solutions on low budgets
-Best practices for adapting to regulatory requirements in both large and small organizations
-Real-world case studies on successful collaboration between big pharma and startups